312 results on '"Radominska-Pandya, Anna"'
Search Results
2. Control of Steroid, Heme, and Carcinogen Metabolism by Nuclear Pregnane X Receptor and Constitutive Androstane Receptor
3. An Essential Role for Nuclear Receptors SXR/PXR in Detoxification of Cholestatic Bile Acids
4. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?
5. Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds
6. Effect of Retinoids on UDP-Glucuronosyltransferase 2B7 mRNA Expression in Caco-2 Cells
7. Natural and Synthetic Cannabinoids Reduce Cell Viability of Ewing Sarcoma TC‐71 Cells Potentially via Non‐canonical CB receptors
8. Human UGT1A8 and UGT1A10 mRNA Are Expressed In Primary Human Hepatocytes
9. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis
10. K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure*,†
11. Photoaffinity labeling of human retinoid X receptor beta (RXRbeta) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRbeta
12. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity
13. Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogens
14. Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics
15. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity
16. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N ‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1 H ‐indole‐3‐carboxamide (STS‐135)
17. Carboxyl residues in the active site of human phenol sulfotransferase (SULTIA1)
18. Direct photoaffinity labeling of cellular retinoic acid-binding protein I (CRABP-I) with all-trans-retinoic acid: identification of amino acids in the ligand binding site
19. Structure of UDP‐Glucuronosyltransferases in Membranes
20. Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues
21. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene
22. Phenylalanine90 and phenylalanine93 are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10
23. Resveratrol is Efficiently Glucuronidated by UDP-Glucuronosyltransferases in the Human Gastrointestinal Tract and in Caco-2 Cells
24. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism
25. Human gastrointestinal sulfotransferases: identification and distribution☆
26. Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7
27. Oxidative Metabolism and Comparative Analysis of Synthetic Cannabinoid N‐(1‐adamantyl)‐1‐(5‐fluoropentyl)indazole‐3‐carboxamide (5F‐AKB‐48) and the Unfluorinated Analog AKB‐48
28. Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22)
29. Oxidative metabolism of synthetic cannabinoid STS-135 by recombinant P450S and human liver microsomes
30. Biological Activity of Resveratrol-Hydroxycinnamic Acid Ester Conjugates
31. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1- (5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).
32. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice
33. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC
34. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants
35. Novel resveratrol triesters demonstrate activity in diverse biological systems
36. Biological Activity of Resveratrol‐Hydroxycinnamic Acid Ester Conjugates
37. Synthetic Cannabinoids: Rapidly Emerging Drugs of Abuse
38. Identification of Novel Variants of the CB 1 Cannabinoid Receptor in Cancer Cells
39. Cannabinoid receptors and their ligands: Role in cancer proliferation
40. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
41. Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/Spice
42. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC.
43. Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines
44. Antitumor 1‐nitroacridine, C‐1748, Decreases Pro‐survival Autophagy and Induces Accumulation of Lipid Droplets Resulting in Apoptosis of Panc‐1 Pancreatic Cancer Cells
45. Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells
46. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
47. Lipid‐dependent proliferation of breast and pancreatic cancer cell lines (605.7)
48. A potential role for human UDP‐glucuronosyltransferase 1A4 promoter SNPs in the pharmacogenomics of Tamoxifen and its derivatives (1141.13)
49. Functional consequences of synthetic cannabinoid metabolites and CYP2C9 polymorphisms (838.4)
50. Special issue: Nanotechnology and Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.